Erick - you have high standards!... COR is already up almost 100% from the $1.07 level. Will you be interested in adding more COR if the FDA gives the green light to CX717? I think the post-positive FDA decision and pre-partnership deal(s) period will be "easy money" time for COR investors. Hopefully there will be even more of a run up from the current $2.00 level; it creates a greater buffer in case of a bad decision from the FDA. And a greater springboard base in case the decision is positive.. Aiming4.